Skip to main content
. 2022 Jul 22;6(8):e10661. doi: 10.1002/jbm4.10661

Table 1.

Baseline Characteristics and Biochemistry

Subject Age Sex Race Tumor location TIO duration FGF23 Phosphate 1,25 (OH)2D TRP P1NP (μg/L) C‐telopeptide (pg/mL) Alkaline phosphatase
Intact C‐terminal
Normal range/units years years <52 pg/mL <180 RU/mL 2.5–4.5 mg/dL 20–79 pmol/L 85%–95% μ/L a pg/mL a 35–105 U/L
1 41 M W C7 vertebra 10 1459 500 1.2 6 61 35 261 87
2 40 M B Greater trochanter of the femur 6 3415 2170 1.5 12 42 67 786 89
3 27 F B Nonlocalized 10 105 216 1.7 32 92 187 425 191
4 27 F W Nonlocalized 10 556 370 1.8 40 72 62 414 161

All subjects discontinued calcitriol and phosphate 3 days prior to baseline labs.

1,25(OH)2D = 1,25(OH)2 vitamin D; 25(OH)D = 25‐OH vitamin D; B = black; FGF23 = fibroblast growth factor 23; iPTH = intact parathyroid hormone; P1NP = propeptide of type 1 procollagen; TmP/GFR = ratio of the maximum rate of tubular phosphate reabsorption to the glomerular filtration rate; TRP = tubular reabsorption of phosphate; W = white.

a

Gender and age‐specific normal ranges: C‐telopeptide male 31–50 years: 93–630 pg/mL; C‐telopeptide female premenopausal: 25–573 pg/mL; P1NP male: 22–87 μ/L; P1NP female: 19–83 μ/L.